Trial 3
|
14:0a
|
16:0b
|
18:1c
|
22:6n-3d
|
---|
|
(n = 10)
|
(n = 10)
|
(n = 10)
|
(n = 10)
|
---|
I-0.5
|
3.23 ± 0.05**
|
15.85 ± 0.37**
|
29.18 ± 0.38
|
7.52 ± 0.20**
|
I-1
|
3.31 ± 0.07
|
14.94 ± 0.47
|
29.49 ± 0.76
|
7.80 ± 0.20
|
I-2
|
3.37 ± 0.06
|
15.82 ± 0.32**
|
28.01 ± 0.65*
|
7.78 ± 0.21*
|
I-C
|
5.78 ± 1.55
|
12.67 ± 1.34
|
23.47 ± 2.66
|
8.64 ± 0.28
|
- Values are shown as mean ± SEM.
- *P < 0.05, ** P < 0.01: significant differences in comparison with control
-
a14:0 Kruskal-Wallis H-test: χ
2 = 7.8, df = 3, P = 0.01
-
b16:0 Kruskal-Wallis H-test: χ
2 = 7.8, df = 3, P = 0.027; I-0.5 vs I-C P = 0.0096; I-2 vs I-C P = 0.009
-
c18:1 Kruskal-Wallis H-test: χ
2 = 7.8, df = 3, P = 0.03
-
d22:6n-3 ANOVA: F
(3,34) = 4.5; I-0.5 vs I-C P = 0.0064; I-2 vs I-C P = 0.05)
- Lice infected (I) fish were fed inclusion levels of 0% GLs-containing raw ingredient (I-C), 0.5% (I-0.5), 1% (I-1) and 2% (I-2). Levels of 14:0, 16:0, 18:1, 22:6n-3 are shown, as they were the only parameters that were significantly different in the One-way ANOVA or Kruskal-Wallis test